Erich Strauss

Title: Erich Strauss: Innovator in Complement-Associated Conditions

Introduction

Erich Strauss is a notable inventor based in San Francisco, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of degenerative diseases. With a total of 2 patents, his work focuses on innovative methods and compositions that address complex health issues.

Latest Patents

One of his latest patents is titled "Compositions and method for treating complement-associated conditions." This invention provides methods and compositions for treating various degenerative diseases, such as age-related macular degeneration (AMD), using a factor D inhibitor, which may include an anti-factor D antibody or an antigen-binding fragment thereof. Additionally, the patent outlines methods for selecting or identifying patients suitable for treatment with a factor D inhibitor, incorporating the use of prognostic and predictive biomarkers. Another significant patent is "Compositions for detecting complement factor H (CFH) and complement factor I (CFI) polymorphisms," which also focuses on treating degenerative diseases with similar methodologies.

Career Highlights

Erich Strauss is currently associated with Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to contribute to groundbreaking research and advancements in the medical field.

Collaborations

Throughout his career, Erich has collaborated with esteemed colleagues, including Brian Yaspan and Robert Royal Graham. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in healthcare.

Conclusion

Erich Strauss stands out as a prominent inventor in the realm of medical innovations, particularly in addressing complement-associated conditions. His patents and work at Genentech reflect his commitment to improving patient outcomes through advanced therapeutic methods.